The New England Journal of MedicineArtificial Intelligence in Medicine

Expanding Horizons of AI in Medicine: Insights and Challenges

The integration of artificial intelligence (AI) into the medical field is rapidly advancing, marking significant strides in healthcare efficiency and patient care. This article outlines the burgeoning role of AI technologies across various medical applications, highlighting both the opportunities they present and the challenges they pose. As the medical community navigates these developments, understanding the implications of AI is critical for enhancing treatment outcomes and operational practices in healthcare settings.

Key Points:

• The Journal has launched a new series titled “AI in Medicine” in response to the surging interest in AI applications within the healthcare sector, illustrating the growing relevance of this technology.
• A new journal, NEJM AI, is set to launch in 2024, focusing on providing a high-quality forum for sharing resources and discussing the potential and limitations of medical AI.
• AI applications in medicine are diverse, ranging from automating medical note dictation to aiding in health insurance claims and interpreting medical images like radiographs and histology.
• Despite the potential for increased operational efficiency, AI technologies can be limited by their fragility, domain-specific functionality, and inherent biases that may disproportionately impact marginalized groups.
• The rapid evolution of AI technology is predominantly driven by commercial interests, with significant developments often coming from companies with financial stakes in their products, necessitating transparency and conflict of interest disclosures in scholarly publications.
• Ethical, governance, and regulatory standards in the deployment of AI systems in medicine are crucial to ensure safety and efficacy, aligning with the rigorous testing standards applied to other medical technologies.
• The upcoming NEJM AI journal will emphasize rigorous methodology in evaluating AI applications to ensure their utility and safety in clinical settings.

According to the McKinsey Global Institute, AI could potentially deliver up to $100 billion annually across the US healthcare system by optimizing innovations, improving the efficiency of research and clinical trials, and creating new tools for physicians, consumers, insurers, and regulators.

More on Artificial Intelligence (AI)